A Case of Neonatal Neutropenia Due to Anti-Fc Gamma Receptor IIIb Isoantibodies Treated with Recombinant Human Granulocyte Colony Stimulating Factor

Alloimmunization to granulocyte-specific antigens can occur during pregnancy. Maternal antibodies of IgG class can cross the placenta to result in alloimmune neonatal neutropenia. Antibodies to human neutrophil antigens anti-HNA-1a, HNA-1b, and HNA-2a have been most commonly reported to cause alloimmune neonatal neutropenia. Isoantibodies to Fc gamma RIIIb (CD16) if mother is a HNA-null phenotype are rarely involved in neonatal neutropenia. We report on a case of severe neutropenia (440 neutrophils/μL) due to anti-Fc gamma RIIIb (CD16) isoimmunization. On day 14 severe omphalitis developed, which was treated for 7 days by an antibiotic (ceftriaxone in a dose of 80 mg/kg/d) according to umbilical swab finding. Omphalitis persisted for 10 days in spite of antibiotic therapy and only resolved upon the introduction of rhG-CSF therapy. Therapy with rh-GCSF proved efficient and led to neutrophil count increase to 1970/μL and cure of omphalitis. However, therapeutic effect on granulocyte count was of transient nature, as granulocyte count fell to 760 n/μL on day 4 of therapy discontinuation. Neutropenia persisted for 2 months. The newborn was discharged from the hospital on day 26 with normal clinical status with clinical and laboratory control examinations at 2-week intervals. No additional infections were observed during the course of neutropenia.

[1]  A. Hirt,et al.  Risk prediction of fever in neutropenia in children with cancer: A step towards individually tailored supportive therapy? , 2008, Pediatric blood & cancer.

[2]  J. Bux,et al.  Human neutrophil alloantigens , 2008, Vox sanguinis.

[3]  Mitsuaki Suzuki,et al.  Granulocyte‐colony stimulating factor for the treatment of ritodrine‐induced neutropenia , 2008, The journal of obstetrics and gynaecology research.

[4]  V. Blanchette,et al.  Guidelines on the use of intravenous immune globulin for hematologic conditions. , 2007, Transfusion medicine reviews.

[5]  F. Hirayama,et al.  Establishment of cell lines stably expressing HNA‐1a, ‐1b, and ‐2a antigen with low background reactivity in flow cytometric analysis , 2007, Transfusion.

[6]  Y. Fung,et al.  Alloimmune neonatal neutropenia: Can we afford the consequences of a missed diagnosis? , 2006, Journal of paediatrics and child health.

[7]  J. Palmblad,et al.  Neutrophil elastase and granulocyte colony-stimulating factor receptor mutation analyses and leukemia evolution in severe congenital neutropenia patients belonging to the original Kostmann family in northern Sweden. , 2006, Haematologica.

[8]  O. Petersen.  Die praktische Bedeutung der Entwicklungshemmungen der Haut , 1912, Archiv für Dermatologie und Syphilis.

[9]  H. Takita,et al.  Intravenous gammaglobulin in treatment of isoimmune neonatal neutropenia , 1988, European Journal of Pediatrics.

[10]  J. DaCosta,et al.  Enzyme replacement therapy in mucopolysaccharidosis type II (Hunter syndrome): a preliminary report , 2002, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[11]  A. Maheshwari,et al.  Immune‐mediated neutropenia in the neonate , 2002, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[12]  R. Siebert,et al.  FCGR3 variants and expression of human neutrophil antigen‐1a, ‐1b, and ‐1c in the populations of northern Germany and Uganda , 2002, Transfusion.

[13]  A. Maheshwari,et al.  Resistance to recombinant human granulocyte colony-stimulating factor in neonatal alloimmune neutropenia associated with anti-human neutrophil antigen-2a (NB1) antibodies. , 2002, Pediatrics.

[14]  K. Maślanka,et al.  Isoimmune neonatal neutropenia due to anti‐Fcgamma RIIIb antibody in a mother with an Fcgamma RIIIb deficiency , 2001, Transfusion medicine.

[15]  J. Bux.  Granulocyte immunology. , 2001, Wiener klinische Wochenschrift.

[16]  G. Tortorolo,et al.  Transient Effect of Granulocyte Colony-Stimulating Factor in Allo-Immune Neonatal Neutropenia , 2000, Neonatology.

[17]  Dirk,et al.  Neutrophil FcyRIIIb Deficiency, Nature, and Clinical Consequences: A Study of 21 Individuals From 14 Families , 2000 .

[18]  G. Latini,et al.  Different responses to granulocyte colony‐stimulating factor treatment in siblings with alloimmune neonatal neutropenia , 1999, Acta paediatrica.

[19]  D. Roos,et al.  Neutrophil Fc gamma RIIIb deficiency, nature, and clinical consequences: a study of 21 individuals from 14 families. , 1995, Blood.

[20]  A. Borne,et al.  Isoimmune neonatal neutropenia caused by Fc gamma RIIIb antibodies in a Spanish child , 1995, Transfusion.

[21]  C. Mueller-Eckhardt,et al.  NA gene frequencies in the German population, determined by polymerase chain reaction with sequence‐specific primers , 1995, Transfusion.

[22]  D. Stroncek,et al.  Treatment of alloimmune neonatal neutropenia with granulocyte colony-stimulating factor. , 1994, The Journal of pediatrics.

[23]  C. Mueller-Eckhardt,et al.  Analysis of granulocyte‐reactive antibodies using an immunoassay based upon monoclonal‐antibody‐specific immobilization of granulocyte antigens , 1993, Transfusion medicine.

[24]  D. Stroncek,et al.  Prolonged neutropenia resulting from antibodies to neutrophil‐specific antigen NB1 following marrow transplantation , 1993, Transfusion.

[25]  C. Mueller-Eckhardt,et al.  Serological and clinical aspects of granulocyte antibodies leading to alloimmune neonatal neutropenia , 1992, Transfusion medicine.

[26]  P. Bierling,et al.  Frequency of the polymorphonuclear neutrophil Fc gamma receptor III deficiency in the French population and its involvement in the development of neonatal alloimmune neutropenia. , 1992, Blood.

[27]  R. Kuijpers,et al.  Maternal genomic neutrophil FcRIII deficiency leading to neonatal isoimmune neutropenia. , 1990, Blood.

[28]  M. Clay,et al.  A Microtiter Modification of Granulocyte Immunofluorescence 1 , 1985, Vox sanguinis.

[29]  P. Lalezari,et al.  Neutrophil-specific antigens: immunology and clinical significance. , 1974, Seminars in hematology.